Article Details

Brokers Set Expectations for Galmed Pharmaceuticals Ltd.'s FY2022 Earnings (NASDAQ:GLMD)

Retrieved on: 2022-05-23 17:52:10

Tags for this article:

Click the tags to see associated articles and topics

Brokers Set Expectations for Galmed Pharmaceuticals Ltd.'s FY2022 Earnings (NASDAQ:GLMD). View article details on hiswai:

Excerpt

Millennium Management LLC now owns 53,239 shares of the biopharmaceutical company's stock valued at $97,000 after purchasing an additional 40,203 ...

Article found on: www.defenseworld.net

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up